Chinese Health announced that the company plans to issue A-shares to no more than 35 specific targets, raising no more than 709 million yuan in total capital, and issuing no more than 50 million shares. After deducting issuance fees, the funds raised are intended to be used for intelligent manufacturing and sorting center projects, pharmaceutical R&D projects, information technology construction projects, and supplementary working capital. The offering is subject to review and approval by the company's shareholders' meeting, review and approval by the Shenzhen Stock Exchange, and registration by the China Securities Regulatory Commission.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.